[en] In this Registry study, manipulation of the CBUs
aimed at volume reduction was not shown to infl uence the clinical
outcome, indicating a satisfactory validation of the associated
technologies across the banks. Cells viability assessment methodology
varied among banks. Further eff orts to standardize the
quality controls before CBU release are needed.
Disciplines :
Hematology
Author, co-author :
SACCARDI, R
Tucunduva, L
Ruggeri, A
Ionescu, I
Koegler, G
Querol, S
Lecchi, L
Pouthier, F
Bittencourt, H
Kenzey, C
Gluckman, E
Labopin, M
BAUDOUX, Etienne ; Centre Hospitalier Universitaire de Liège - CHU > Thérapie cellulaire
